Table 7 Summary of robenacoxib concentration (ng/mL); mean (SD), N = 8
Day | Time (h) | Group 2 | Group 3 | Group 4 | |||
|---|---|---|---|---|---|---|---|
1 | 1 | 2514 | (1339) | 1760 | (1401) | 2761 | (1728) |
1 | 5 | 44 | (32) | 151 | (223) | 136 | (87) |
6 | 1 | 1447 | (1473) | 1608 | (1164) | 2610 | (2083) |
6 | 5 | 30 | (15) | 72 | (74) | 73 | (37) |
8 | 1 | 1039 | (1026) | 1677 | (1477) | 4991 | (4129) |
8 | 5 | 78 | (80) | 212 | (149) | 191 | (154) |
11 | 1 | 1564 | (582) | 2014 | (573) | 3015 | (1336) |
11 | 5 | 435 | (202) | 1126 | (344) | 1913 | (1101) |
14 | 1 | 2825 | (3489) | 1603 | (1442) | 1822 | (1413) |
14 | 5 | 38 | (43) | 110 | (118) | 103 | (63) |
69 | 1 | 2896 | (1369) | 2653 | (2530) | 3915 | (2533) |
69 | 5 | 53 | (54) | 128 | (105) | 154 | (129) |
74 | 1 | 1290 | (955) | 1232 | (1632) | 4759 | (2889) |
74 | 5 | 67 | (52) | 157 | (180) | 104 | (61) |
76 | 1 | 3467 | (2004) | 2791 | (2447) | 4492 | (4924) |
76 | 5 | 166 | (178) | 366 | (276) | 1047 | (1421) |
79 | 1 | 1269 | (405) | 1402 | (386) | 2245 | (1137) |
79 | 5 | 944 | (299) | 2050 | (428) | 3133 | (999) |
82 | 1 | 1130 | (563) | 2118 | (1349) | 2541 | (2049) |
82 | 5 | 45 | (50) | 110 | (113) | 114 | (126) |